Health
Study shows Oxford Covid vaccine has less protection against South African variant – The Guardian
Researchers say vaccines’ focus must shift to protecting people from hospitalisation and death
The Oxford/AstraZeneca vaccine will not stop people becoming ill if they contract the South African variant of Covid-19, researchers have confirmed, warning that vaccines focus needs to shift from population immunity to protecting individuals from hospitalisation and death.
The small study in 2,000 people aged 31, who are less likely to become severely ill, adds to evidence from big trials of other vaccines carried out after the variant appeared in South Africa. Trial data from the Janssen and Novavax…
-
Noosa News23 hours agoMan dies after stabbing in inner-city unit
-
Noosa News21 hours agoBrisbane man, 39, dies after stabbing at inner city home in early morning attack, prompting investigation
-
General15 hours agoChinese spies, ports and Donald | Scam of the Week
-
General15 hours agoLiberals dump NSW candidate who said women should not serve in ADF combat